Hemagen Diagnostics, Inc.
HMGN
$0.00
$0.000.00%
| 09/30/2012 | 06/30/2012 | ||||
|---|---|---|---|---|---|
| Revenue | -7.59% | -14.71% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -7.59% | -14.71% | |||
| Cost of Revenue | -4.17% | -35.02% | |||
| Gross Profit | -11.33% | 29.39% | |||
| SG&A Expenses | -8.08% | 2.85% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.22% | -22.48% | |||
| Operating Income | -255.28% | 90.33% | |||
| Income Before Tax | -23.39% | 45.77% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -23.39% | 45.77% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -23.39% | 45.77% | |||
| EBIT | -255.28% | 90.33% | |||
| EBITDA | -125.45% | 133.49% | |||
| EPS Basic | -23.53% | 45.86% | |||
| Normalized Basic EPS | -24.53% | 45.36% | |||
| EPS Diluted | -5.00% | 50.00% | |||
| Normalized Diluted EPS | -24.53% | 45.36% | |||
| Average Basic Shares Outstanding | 0.01% | 0.03% | |||
| Average Diluted Shares Outstanding | 0.01% | 0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
